(4R)-8-(8-naphthalen-1-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine
C24H26N6S — CID 139427831
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-8-(8-naphthalen-1-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine
(4R)-8-(8-naphthalen-1-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine (PubChem CID 139427831) has the molecular formula C24H26N6S and a molecular weight of 430.58 g/mol. Its IUPAC name is (4R)-8-(8-naphthalen-1-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine.
Molecular Properties
| Compound Name | (4R)-8-(8-naphthalen-1-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine |
|---|---|
| PubChem CID | 139427831 |
| Molecular Formula | C24H26N6S |
| Molecular Weight | 430.58 g/mol |
| Exact Mass | 430.19 |
| IUPAC Name | (4R)-8-(8-naphthalen-1-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine |
| SMILES | N[C@@H]1CCCC12CCN(c1ncc(Sc3cccc4ccccc34)c3nncn13)CC2 |
| InChI | InChI=1S/C24H26N6S/c25-21-9-4-10-24(21)11-13-29(14-12-24)23-26-15-20(22-28-27-16-30(22)23)31-19-8-3-6-17-5-1-2-7-18(17)19/h1-3,5-8,15-16,21H,4,9-14,25H2/t21-/m1/s1 |
| InChIKey | FXLBXFGNPPUMFT-OAQYLSRUSA-N |
| XLogP | 4.53 |
| TPSA | 72.34 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.58 |
| LogP ≤ 5 | 4.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139427831 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.